Cargando…

Efficacy and Safety of Oral Fosfomycin-Trometamol in Male Urinary Tract Infections with Multidrug-Resistant Enterobacterales

Background: Antimicrobial drugs to treat male urinary tract infection (UTI) with multidrug-resistant Enterobacterales are limited. We studied oral fosfomycin-trometamol (FT) in this situation. The objective was to assess the clinical cure rate in patients presenting UTIs treated with oral FT. Method...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bouiller, Kévin, Zayet, Souheil, Lalloz, Paul-Emile, Potron, Anaïs, Gendrin, Vincent, Chirouze, Catherine, Klopfenstein, Timothée
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868337/ https://www.ncbi.nlm.nih.gov/pubmed/35203801 http://dx.doi.org/10.3390/antibiotics11020198

Ejemplares similares

Re: Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM
por: Klopfenstein, Timothée, et al.
Publicado: (2022)

Shigella sonnei, an emerging multidrug-resistant sexually transmitted pathogen in Franche-Comté, France
por: Zayet, Souheil, et al.
Publicado: (2021)

A Comparative Systematic Review of COVID-19 and Influenza
por: Osman, Molka, et al.
Publicado: (2021)

Increased COVID-19 Severity among Pregnant Patients Infected with SARS-CoV-2 Delta Variant, France
por: Zayet, Souheil, et al.
Publicado: (2022)

Simultaneous co-infection with Omicron (B.1.1.529) and Delta (21A/478K.V1) SARS-CoV-2 variants confirmed by whole genome sequencing
por: Zayet, Souheil, et al.
Publicado: (2022)

Lactobacillus rhamnosus a cause of Gram-positive rods bacteremia after prophylactic probiotic consumption
por: Zayet, Souheil, et al.
Publicado: (2023)

Is There Still a Place for Tocilizumab in Coronavirus Disease 2019?
por: Klopfenstein, Timothée, et al.
Publicado: (2021)

Recurrence of COVID-19 after recovery ? A case series in health care workers, France
por: Zayet, Souheil, et al.
Publicado: (2021)

Recurrent obstructive prostatitis revealing granulomatosis with polyangiitis
por: Clerc, Melitine, et al.
Publicado: (2021)

Antibiotics and Therapeutic Agent Prescription in COVID-19 Management
por: Zayet, Souheil, et al.
Publicado: (2022)

Third of patients have gustatory dysfunction 9 months after SARS-CoV-2 infection: the ANOSVID study
por: Klopfenstein, Timothée, et al.
Publicado: (2022)

Asthma and Cacosmia Could Be Predictive Factors of Olfactory Dysfunction Persistence 9 Months after SARS-CoV-2 Infection: The ANOSVID Study
por: Tipirdamaz, Can, et al.
Publicado: (2022)

Fosfomycin Pharmacokinetic Profile in Plasma and Urine and Quantitative Estimation in Prostate and Seminal Vesicles after One and Two Consecutive Doses of Oral Fosfomycin Trometamol in Healthy Male Volunteers
por: Di Stefano, Andrea F. D., et al.
Publicado: (2022)

Oral fosfomycin for treatment of acute bacterial prostatitis caused by multidrug-resistant Enterobacterales
por: Burgos, Joaquin, et al.
Publicado: (2023)

COVID-19: comparative clinical features and outcome in 114 patients with or without pneumonia (Nord Franche-Comte Hospital, France)
por: Kadiane-Oussou, N’dri Juliette, et al.
Publicado: (2020)

Diarrhea: An underestimated symptom in Coronavirus disease 2019
por: Klopfenstein, Timothée, et al.
Publicado: (2020)

Natural history of COVID-19: back to basics
por: Zayet, S., et al.
Publicado: (2020)

Clinical spectrum of ocular manifestations in COVID-19: a case series
por: Zayet, Souheil, et al.
Publicado: (2023)

2819. Clinical Outcomes of Fosfomycin Treatment in E. coli vs. Non-E. coli Enterobacterales Urinary Tract Infection
por: Traugott, Kristi, et al.
Publicado: (2023)

Postoperative Prevention of Urinary Tract Infections in Patients after Urogynecological Surgeries—Nonantibiotic Herbal (Canephron) versus Antibiotic Prophylaxis (Fosfomycin Trometamol): A Parallel-Group, Randomized, Noninferiority Experimental Trial
por: Wawrysiuk, Sara, et al.
Publicado: (2022)

Campylobacter fetus Invasive Infections and Risks for Death, France, 2000–2021
por: Zayet, Souheil, et al.
Publicado: (2023)

Fosfomycin resistance mechanisms in Enterobacterales: an increasing threat
por: Mattioni Marchetti, Vittoria, et al.
Publicado: (2023)

Angioedema and COVID-19: A New Dermatological Manifestation?
por: Royer, Pierre-Yves, et al.
Publicado: (2021)

New loss of smell and taste: Uncommon symptoms in COVID-19 patients on Nord Franche-Comte cluster, France
por: Klopfenstein, Timothée, et al.
Publicado: (2020)

Clinical features of COVID-19 and influenza: a comparative study on Nord Franche-Comte cluster
por: Zayet, Souheil, et al.
Publicado: (2020)

Multidrug-Resistant Enterobacterales in Community-Acquired Urinary Tract Infections in Djibouti, Republic of Djibouti
por: Mohamed, Hasna Said, et al.
Publicado: (2022)

COVEVOL: Natural Evolution at 6 Months of COVID-19
por: Messin, Louise, et al.
Publicado: (2021)

Leclercia adecarboxylata as Emerging Pathogen in Human Infections: Clinical Features and Antimicrobial Susceptibility Testing
por: Zayet, Souheil, et al.
Publicado: (2021)

Oral and intravenous fosfomycin in complicated urinary tract infections
por: López-Montesinos, Inmaculada, et al.
Publicado: (2019)

Trometamol: No improvement: case report
Publicado: (2022)

Fosfomycin trometamol vs ciprofloxacin for antibiotic prophylaxis before transrectal ultrasonography-guided prostate biopsy: A meta-analysis of clinical studies
por: Freitas, Daniel Melecchi de Oliveira, et al.
Publicado: (2019)

Acute Cerebral Stroke with Multiple Infarctions and COVID-19, France, 2020
por: Zayet, Souheil, et al.
Publicado: (2020)

Atypical miller-fisher syndrome after COVID-19 and sleeve gastrectomy: Contribution of neurochemical markers to early diagnosis
por: Zayet, Souheil, et al.
Publicado: (2022)

Contribution of anosmia and dysgeusia for diagnostic of COVID-19 in outpatients
por: Zayet, Souheil, et al.
Publicado: (2020)

Risk Factors for Community-Acquired Urinary Tract Infections Caused by Multidrug-Resistant Enterobacterales in Thailand
por: Assawatheptawee, Kanit, et al.
Publicado: (2022)

Asymptomatic cerebral abscesses after pleuropulmonary Nocardia farcinica infection
por: Zayet, S., et al.
Publicado: (2020)

Fosfomycin for management of persistent female lower urinary tract infection
por: Joob, Beuy, et al.
Publicado: (2018)

Oral and Intravenous Fosfomycin for the Treatment of Complicated Urinary Tract Infections
por: Zhanel, George G., et al.
Publicado: (2020)

2420. A Real-World Perspective on the Efficacy of Fosfomycin for Treatment of Multidrug-Resistant Pathogens Causing Urinary Tract Infections
por: Babiker, Ahmed, et al.
Publicado: (2018)

Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial
por: Sojo-Dorado, Jesús, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jc00f9qie74oglbccv6la73tgh